Galera Therapeutics Insider Trading Activity | OTC:GRTX | Benzinga

Galera Therapeutics Inc Insider Trading Activity

GRTXOTCQB

Trade with Public

Trade with Public

$0.0740

-0.14-65.60%

Last update: Apr 14, 9:29 AM

Overview News Earnings Analyst RatingsInsider TradesShort Interest

Galera Therapeutics Insider Trading Activity | OTC:GRTX | Benzinga

Track the latest Galera Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Galera Therapeutics stock.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are Galera Therapeutics Inc Insiders Doing?

Insiders have report no purchases/sales in the last 30 days.

Notable Recent Insider Buys and Sales

There has been no Insider buying or selling in the last 90 days.

Ownership Statistics for Galera Therapeutics Inc

Shares Outstanding

160.430M

Shares Float

141755842.0%

Insider Shares Owned

8.031M

Insider Percentage Owned

10.6%

Institutional Shares Held

7.000

Institutional Percentage Held

0.00%

Loading calendar...

FAQ

Q

Is insider trading legal?

A

Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.

Q

What are some examples of market manipulation?

A

Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

GRTX Insider Trading News

Galera Therapeutics And 2 Other Stocks Under $3 Insiders Are Buying

The Dow Jones index closed lower by over 50 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Avi Kapoor


Nov 24, 2025	Mel Sorensen	PRESIDENT AND CEO	-70.00K	$0.02	-$1.41K	SELL	-26.41%	195.03K	Nov 20	View
Jan 02, 2025	Nancy T Chang	—	7.64M	$0.07	$499.98K	BUY	∞	7.64M	Dec 30	View
Aug 20, 2024	Mel Sorensen	PRESIDENT AND CEO	-67.02K	$0.07	-$4.83K	SELL	-20.18%	265.03K	Aug 16	View
Feb 26, 2024	Yair Schneid	10% OWNER	932.40K	$0.18	$166.42K	BUY	13.11%	8.04M	Jan 29 - Feb 08	View
Mar 20, 2023	Mark Bachleda	CHIEF COMMERCIAL OFFICER	11.00K	$2.25	$24.72K	BUY	∞	11.00K	Mar 16	View
Mar 14, 2023	Mel Sorensen	PRESIDENT AND CEO	100.00K	$1.68	$168.12K	BUY	43.10%	332.04K	Mar 10	View
Mar 14, 2023	Chris Degnan	CHIEF FINANCIAL OFFICER	10.00K	$1.96	$19.59K	BUY	∞	10.00K	Mar 13	View
Dec 20, 2021	Linda West	DIRECTOR	20.00K	$2.74	$54.80K	BUY	50.00%	60.00K	Dec 17	View
Sep 03, 2021	Jon T Holmlund	CHIEF MEDICAL OFFICER	0.00	$5.45	-$288.45K	SELL-OPTIONS	0.00%	0.00	Sep 01	View
Jun 17, 2021	Linda West	DIRECTOR	10.00K	$9.13	$91.30K	BUY	33.33%	40.00K	Jun 15	View
Jun 04, 2021	Linda West	DIRECTOR	10.00K	$8.65	$86.51K	BUY	50.00%	30.00K	Jun 02	View
Jun 03, 2021	Lawrence M Alleva	DIRECTOR	4.04K	$8.59	$34.74K	BUY	63.95%	10.37K	Jun 01	View
Jun 02, 2021	Linda West	DIRECTOR	20.00K	$8.64	$172.79K	BUY	∞	20.00K	May 28 - Jun 01	View
Feb 19, 2021	Peter Haahr Chief Financial Officer of Novo Holdings A/S	10% OWNER	-500.00K	$10.58	-$5.29M	SELL	-16.90%	2.46M	Feb 18	View
Nov 17, 2020	Lawrence M Alleva	—	2.33K	$10.22	$23.77K	PURCHASE	58.13%	6.33K	Nov 13	View
Nov 16, 2020	Joel F Sussman	—	0.00	$5.73	-$178.57K	OPTION EXERCISE	0.00%	0.00	Nov 12 - Nov 13	View
Oct 28, 2020	Jon T Holmlund	—	0.00	$8.71	-$28.21K	OPTION EXERCISE	0.00%	0.00	Oct 26	View
Oct 19, 2020	Peter Haahr Chief Financial Officer of Novo Holdings A/S	—	-450.00K	$11.00	-$4.95M	SELL	-13.20%	2.96M	Oct 15	View
Oct 07, 2020	Jon T Holmlund	—	0.00	$6.55	-$115.86K	OPTION EXERCISE	0.00%	0.00	Oct 05 - Oct 06	View
Jun 22, 2020	Novartis Bioventures Ltd AG NOVARTIS	—	-1.00M	$8.25	-$8.27M	SELL	-28.88%	2.47M	Jun 18 - Jun 19	View
Jun 17, 2020	Novartis Bioventures Ltd AG NOVARTIS	—	-19.39K	$9.21	-$178.61K	SELL	-0.56%	3.47M	Jun 15 - Jun 17	View
Jun 12, 2020	Novartis Bioventures Ltd AG NOVARTIS	—	-17.23K	$9.33	-$160.81K	SELL	-0.49%	3.49M	Jun 10 - Jun 12	View
Jun 09, 2020	Novartis Bioventures Ltd AG NOVARTIS	—	-21.31K	$9.57	-$203.90K	SELL	-0.60%	3.51M	Jun 05 - Jun 09	View
Jun 04, 2020	Novartis Bioventures Ltd AG NOVARTIS	—	-14.96K	$9.68	-$144.85K	SELL	-0.42%	3.53M	Jun 02 - Jun 04	View
May 28, 2020	Jon T Holmlund	—	0.00	$6.54	-$7.56K	OPTION EXERCISE	0.00%	0.00	May 26	View
May 22, 2020	Jon T Holmlund	—	0.00	$6.54	-$23.42K	OPTION EXERCISE	0.00%	0.00	May 20 - May 21	View
May 12, 2020	Jon T Holmlund	—	0.00	$6.54	-$65.12K	OPTION EXERCISE	0.00%	0.00	May 08 - May 12	View
May 07, 2020	Jon T Holmlund	—	0.00	$6.57	-$72.76K	OPTION EXERCISE	0.00%	0.00	May 05 - May 07	View
Dec 17, 2019	Lawrence Alleva	DIRECTOR	4.00K	$9.78	$39.14K	BUY	∞	4.00K	Dec 13	View
Nov 14, 2019	Clarus IVA LP Clarus IVB LP Clarus IVC LP Clarus IVD LP Clarus IV GP LP	10% OWNER	1.68M	$12.00	$3.00M	BUY	∞	130.44K	Nov 12	View
Nov 14, 2019	Blackstone Clarus GP LP Blackstone Clarus GP LLC Blackstone Holdings II LP Blackstone Holdings III GP LLC Blackstone Group Inc Blackstone Group Management LLC STEPHEN SCHWARZMAN	10% OWNER	1.68M	$12.00	$3.00M	BUY	∞	130.44K	Nov 12	View
Nov 14, 2019	Peter Haahr Chief Financial Officer of Novo Holdings A/S	10% OWNER	3.41M	$12.00	$6.00M	BUY	∞	3.41M	Nov 12	View
Nov 12, 2019	New Enterprise Associates LP Peter Sonsini PATRICK KERINS NEA Partners LP NEA GP LTD PETER BARRIS FOREST BASKETT Anthony Florence Jr DAVID MOTT SCOTT SANDELL	10% OWNER	4.36M	$12.00	$5.00M	BUY	∞	4.36M	Nov 12	View
Nov 12, 2019	Sofinnova Venture Partners IX LP Sofinnova Management IX LLC MICHAEL POWELL JAMES HEALY Anand Mehra	DIRECTOR	3.08M	$12.00	$9.00M	BUY	∞	3.08M	Nov 12	View
Nov 12, 2019	Novartis Bioventures Ltd AG NOVARTIS	10% OWNER	3.54M	$12.00	$3.00M	BUY	∞	3.54M	Nov 12	View